Old Web
English
Sign In
Acemap
>
authorDetail
>
Shahida Baqar
Shahida Baqar
National Institutes of Health
Oral administration
Immunology
Antigen
Biology
Antibody titer
3
Papers
17
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Multiple Ascending Dose Phase 1 Clinical Study of Safety, Tolerability and Pharmacokinetics of CRS3123, a Narrow Spectrum Agent with Minimal Disruption of Normal Gut Microbiota
2019
Antimicrobial Agents and Chemotherapy
Barbara Lomeli
Hal Galbraith
Jared Schettler
George A. Saviolakis
Wael El-Amin
Blaire L. Osborn
Jacques Ravel
Keith Hazleton
Catherine A. Lozupone
Ron Evans
Stacie J. Bell
Urs A. Ochsner
Thale Jarvis
Shahida Baqar
Nebojsa Janjic
Show All
Source
Cite
Save
Citations (6)
A Phase 1 dose escalating study of double mutant heat-labile toxin LTR192G/L211A (dmLT) from Enterotoxigenic Escherichia coli (ETEC) by sublingual or oral immunization.
2019
Vaccine
David I. Bernstein
Marcela F. Pasetti
Rebecca C. Brady
Amanda D. Buskirk
Rezwanul Wahid
Michelle Dickey
Mitchell B. Cohen
Holly Baughman
Jill El-Khorazaty
Nicole Maier
Marcelo B. Sztein
Shahida Baqar
A. Louis Bourgeois
Show All
Source
Cite
Save
Citations (11)
1